Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|April 13, 2024
Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99mEkaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of FibrosisIrina Velikyan, Ulrika Rosenström, Maria Rosestedt, et al.
ACS Pharmacology & Translational Science|October 16, 2025
Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium-99mEkaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström, et al.
Pharmaceuticals (Basel, Switzerland)|June 9, 2016
Feasibility of Multiple Examinations Using (68)Ga-Labelled Collagelin Analogues: Organ Distribution in Rat for Extrapolation to Human Organ and Whole-Body Radiation DosimetryIrina Velikyan, Ulrika Rosenström, Thomas N Bulenga, et al.
Acta Diabetologica|September 12, 2017
Species differences in pancreatic binding of DO3A-VS-Cys40-Exendin4Olof Eriksson, Ulrika Rosenström, Ram K Selvaraju, et al.
ACS Omega|April 29, 2024
Two Novel [68Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar11]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate CancerPanagiotis Kanellopoulos, Ekaterina Bezverkhniaia, Ayman Abouzayed, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 15, 2025
Linker modifications in radiolabeled RM26-based antagonists to gastrin-releasing peptide receptor (GRPR) improved tracers' pharmacokineticsEkaterina Bezverkhniaia, Ayman Abouzayed, Panagiotis Kanellopoulos, et al.
Pharmaceutics|May 28, 2022
Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting RadioligandsFanny Lundmark, Gustav Olanders, Sara Sophie Rinne, et al.
Pharmaceutics|August 7, 2019
Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled CounterpartMaryam Oroujeni, Ayman Abouzayed, Fanny Lundmark, et al.
Journal of Medicinal Chemistry|September 29, 2006
Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptorsUlrika Rosenström, Christian Sköld, Gunnar Lindeberg, et al.
Pageof 4